Our results strongly suggest that PTBP1, hnRNPA1, and SRSF3 controlled cancer-specific energy metabolism at least in part through affecting the PKM gene expression profile via AS, which was clarified by RIP and IP assays, and that these proteins coding RNA would be targets for RNA medicine. The gene discussed is PTBP1; the disease is cancer.